SLC2A1 and cancer: For example, the enhanced uptake of glucose in cancer cells can be monitored by [18F]fluoro-deoxyglucose ([18F]FDG), a substrate of the glucose transporters (GLUT) overexpressed in cancer cells that has been clinically used for more than three decades for diagnosis, staging, and treatment monitoring in oncology [25,26].